Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)

NCT02768402 is registered in ClinicalTrials.gov with Caisson Interventional LLC as lead sponsor.

NCT NCT02768402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02768402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)
Lead sponsor
Caisson Interventional LLC
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2023
Enrollment
20 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve regurgitation